Understanding Your Autoimmune Panel

Section Editor: Christopher McCudden Ph.D., DABCC, FADLM, FCACB
July 10, 2026

An autoimmune panel is a group of blood tests that look for autoantibodies, which are antibodies the immune system makes against the body’s own tissues. These tests are used to help investigate whether symptoms might be caused by an autoimmune disease, a condition in which the immune system mistakenly attacks healthy parts of the body. Different autoantibodies are linked to different conditions, so the specific tests ordered depend on what a doctor suspects. Importantly, a positive result on its own does not diagnose a disease. Autoimmune antibody results are always interpreted together with a person’s symptoms, physical examination, and other tests.

This article explains what an autoimmune panel measures, how the results are interpreted, and what the individual antibodies you are most likely to see on a report mean, so you can match the name on your report to what it describes.

The reference range that applies to your result is the one printed on your laboratory report, not the typical ranges shown here. Reference ranges vary between laboratories based on the equipment used, the population tested, and individual factors such as age, sex, and pregnancy status. Always compare your result to the reference range printed on your own report, and discuss any abnormal result with your doctor.

What is an autoimmune panel?

An autoimmune panel measures autoantibodies in the blood. Antibodies are proteins made by the immune system that normally attach to germs to help fight infection. In an autoimmune disease, the immune system makes antibodies that attach to the body’s own tissues instead, and these are called autoantibodies. Because different autoantibodies target different tissues, finding a specific one can point to a specific condition. Results may be reported in several ways, including as positive or negative, as a titer (a measure of antibody concentration, such as 1:160), as a staining pattern, or as a numerical value in units. Which form is used depends on the specific test.

How is the test performed?

Autoimmune antibodies are measured from a blood sample drawn from a vein, usually without any special preparation. Testing is often done in steps. A broad screening test, most commonly the antinuclear antibody (ANA) test, may be done first, and if it is positive, more specific antibody tests are added to narrow down the cause. Each antibody is measured by its own laboratory method, so a report may list several results obtained in different ways.

How are the results interpreted?

Understanding a few general principles helps make sense of an autoimmune panel, as these tests are easy to misread when viewed in isolation.

A positive result is not a diagnosis — Autoantibodies can be present without disease, so a positive result only matters when it fits with a person’s symptoms and other findings.
Healthy people can test positive — A low-level positive ANA or rheumatoid factor is common in people without any autoimmune disease, especially women and older adults.
Some tests are sensitive, others are specific — A sensitive test, like ANA, rarely misses the disease it screens for but is positive in many other situations. A specific test, such as anti-double-stranded DNA, is rarely positive in the absence of disease but can miss some cases. The two types of tests are used together.
The titer or level matters — A strongly positive result at a high titer is more likely to be meaningful than a weakly positive one just above the threshold.
A negative result can be useful — Because ANA is positive in nearly everyone with lupus, a negative ANA makes lupus unlikely and can help rule it out.

For all these reasons, autoimmune antibody results are interpreted by a doctor in the context of the whole clinical picture rather than read as a simple yes-or-no for disease.

Common autoimmune antibodies and what they mean

The antibodies below are the ones most often seen on an autoimmune panel. For each, it helps to know which condition it is linked to and how reliable a positive result is.

Antinuclear antibody (ANA)

The antinuclear antibody (ANA) test looks for antibodies directed against parts of the cell nucleus. It is the usual first-line screening test when an autoimmune connective tissue disease such as lupus is suspected. A positive ANA is found in most people with lupus, but it is also positive in other autoimmune conditions and in a meaningful number of healthy people. The result is usually reported as a titer and a staining pattern, and higher titers are more likely to be meaningful. Because a positive ANA is common, it is interpreted together with symptoms and more specific antibody tests.

Anti-double-stranded DNA (anti-dsDNA)

Antibodies against double-stranded DNA (anti-dsDNA) are much more specific for systemic lupus erythematosus (lupus) than ANA. A positive result supports a diagnosis of lupus in the right clinical setting, and the level can rise and fall with disease activity, including with kidney involvement. Unlike ANA, anti-dsDNA is uncommon in people without lupus.

Extractable nuclear antigen (ENA) antibodies

When the ANA is positive, the laboratory often runs a follow-up panel called the extractable nuclear antigen (ENA) antibodies. This panel looks for several more specific antibodies, each linked to particular conditions: anti-Sm (lupus), anti-Ro/SSA and anti-La/SSB (Sjögren disease and lupus), anti-Scl-70 (systemic sclerosis, also called scleroderma), and anti-Jo-1 (a form of muscle inflammation). Which of these is positive helps point toward a specific diagnosis.

Rheumatoid factor (RF)

Rheumatoid factor (RF) is an antibody often present in rheumatoid arthritis, a condition that causes inflammation of the joints. It is helpful but not specific because it is also found in other autoimmune conditions, some infections, and healthy people, particularly older adults. A positive RF supports, but does not confirm, a diagnosis of rheumatoid arthritis.

Anti-CCP (anti-cyclic citrullinated peptide)

Antibodies against cyclic citrullinated peptides (anti-CCP) are more specific for rheumatoid arthritis than rheumatoid factor. A positive anti-CCP strongly supports the diagnosis, can appear early before joint damage develops, and is associated with a higher chance of more severe joint disease. It is often measured together with RF.

Anti-tissue transglutaminase (anti-tTG)

Antibodies against tissue transglutaminase (anti-tTG) are the main blood test used to screen for celiac disease, an immune reaction to gluten that damages the small intestine. The test is most reliable while a person is still eating gluten. A total IgA level is usually measured at the same time because a low IgA level can cause the anti-tTG result to be falsely negative. A positive result is typically followed by a biopsy of the small intestine to confirm the diagnosis.

Smooth muscle antibody (SMA) and anti-LKM-1

Smooth muscle antibody (SMA) and anti-liver-kidney microsomal antibody (anti-LKM-1) are used to investigate autoimmune hepatitis, a condition in which the immune system attacks the liver. SMA, often together with ANA, is linked to type 1 autoimmune hepatitis, while anti-LKM-1 is linked to type 2, which is more common in children. These results are interpreted alongside liver enzyme tests and usually a liver biopsy.

What else can cause a positive result?

A positive autoimmune antibody test does not always mean autoimmune disease, which is why the result is interpreted carefully rather than taken as proof of a condition. Common non-disease causes include ordinary aging, which raises the chance of a low-level positive ANA or rheumatoid factor, and certain infections, which can temporarily trigger these antibodies. Some medications cause a positive ANA and, rarely, a drug-induced form of lupus that improves when the medication is stopped. Pregnancy and other inflammatory conditions can also affect results. For celiac testing, a low total IgA level can cause the anti-tTG result to be falsely negative, which is why total IgA is measured at the same time. Because of these possibilities, a single positive result is interpreted in context and often confirmed with more specific tests.

What happens after a positive result?

A positive autoimmune antibody result guides the next steps rather than settling the diagnosis. Depending on which antibody is positive and the overall clinical picture, the doctor may order more specific antibody tests (for example, an ENA panel after a positive ANA), repeat the test, or refer to a specialist such as a rheumatologist, gastroenterologist, or hepatologist. Some autoimmune diagnoses are confirmed with a biopsy (a small tissue sample examined under the microscope), such as a liver biopsy for autoimmune hepatitis or a small intestine biopsy for celiac disease. Your doctor interprets the antibody results together with your symptoms, examination, and other tests to decide what, if anything, needs to happen next.

Questions to ask your doctor

Which autoimmune antibodies were tested, and why were they ordered for me?
Which of my results were positive, and what titer or level was reported?
Does a positive result mean I have an autoimmune disease, or could it be explained by something else?
Do I need more specific antibody tests to clarify the diagnosis?
Should I be referred to a specialist such as a rheumatologist, gastroenterologist, or hepatologist?
Could any of my medications be affecting these results?
Will any of these tests need to be repeated over time?
Do I need a biopsy or another test to confirm a diagnosis?
If my results are negative, does that rule out an autoimmune condition?
Should my family members be tested for any condition found?